Tenderwize
Back to tender search

Open-house biologics rebate agreement for PEG-Epoetin beta

Techniker Krankenkasse·Hamburg, Germany·Deadline Jan 30, 2028 · 529 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-38 - PEG-Epoetin beta

52/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

52 / 100

Complexity

58 / 100

Risk factors

For monthly inclusion in pharmacy software, complete documents must reach TK by the 3rd day of the previous month; late...

Portal submission is not allowed; contracts must be sent by email with qualified electronic signature or by post, which...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Jan 2028
  • Supply of pharmaceutical products for PEG-Epoetin beta under an open-house rebate agreement.
  • Conclusion of rebate contracts with all suitable pharmaceutical manufacturers meeting the stated conditions.
Show full summary

Open-house supply arrangement for PEG-Epoetin beta pharmaceutical products in Germany, led by Techniker Krankenkasse with HEK and hkk as participating buyers. The contract is non-exclusive, with no individual negotiations, and can be joined at any time during the contract period. The notice states a maximum duration of 24 months from 01.02.2026 to 31.01.2028. No contract value is provided. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post, and the notice says the procurement documents are available online but were not fully analyzed as separate extracted document text is not provided beyond the XML notice.

Risks

For monthly inclusion in pharmacy software, complete documents must reach TK by the 3rd day of the previous month; late...

Portal submission is not allowed; contracts must be sent by email with qualified electronic signature or by post, which...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Applicant must be a pharmaceutical undertaking within the meaning of § 4 Abs. 18 AMG for the relevant medicinal product.
  • Applicant must have its seat in the AMG territory, another EU Member State, or another EEA state.
  • Applicant must hold a valid marketing authorisation for the relevant medicinal product or otherwise be entitled to place it on the market in its own name.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open-house biologics rebate agreement for PEG-Epoetin beta

Open-house supply contract for rebate agreements under § 130c Abs. 1 SGB V for the active substance PEG-Epoetin beta. The lot is nationwide in Germany and is described as non-exclusive, with uniform conditions and no individual negotiations. The extracted XML notice indicates that contracts are opened directly and concluded once the stated conditions are met.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Jan 2026 - Jan 2028

Category

Pharmaceutical products

Deadline

Deadline Jan 30, 2028

Procurement Details

Publication date
03 Dec 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
804419-2025

Documents (1)

Similar tenders